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ABSTRACT
A GGGGCC hexanucleotide repeat expansion in the ﬁrst intron of the C9orf72 gene is the most
common genetic defect associated with amyotrophic lateral sclerosis (ALS) and frontotemporal
dementia (FTD) (C9ALS/FTD). Haploinsufﬁciency and a resulting loss of C9orf72 protein function has
been suggested as a possible pathogenic mechanism in C9ALS/FTD. C9ALS/FTD patients exhibit
speciﬁc ubiquitin and p62/sequestosome-1 positive but TDP-43 negative inclusions in the
cerebellum and hippocampus, indicating possible autophagy deﬁcits in these patients. In a recent
study, we investigated this possibility by reducing expression of C9orf72 in cell lines and primary
neurons and found that C9orf72 regulates the initiation of autophagy. C9orf72 interacts with Rab1a,
preferentially in its GTP-bound state, as well as the ULK1 autophagy initiation complex. As an
effector of Rab1a, C9orf72 controls the Rab1a-dependent trafﬁcking of the ULK1 initiation complex
prior to autophagosome formation. In line with this function, C9orf72 depletion in cell lines and
primary neurons caused the accumulation of p62/sequestosome-1-positive inclusions. In support of
a role in disease pathogenesis, C9ALS/FTD patient-derived iNeurons showed markedly reduced
levels of autophagy. In this Commentary we summarise recent ﬁndings supporting the key role of
C9orf72 in Rab GTPase-dependent regulation of autophagy and discuss autophagy dysregulation as
a pathogenic mechanism in ALS/FTD.
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Introduction
Amyotrophic lateral sclerosis (ALS) is the most common
adult onset motor neuron disorder. ALS is caused by
selective degeneration of upper and lower motor neu-
rons, which leads to progressive muscle weakness, gait
abnormalities, paralysis and ultimately death. Fronto-
temporal dementia (FTD) is the second most common
form of dementia in the under 65s. FTD is characterized
by loss of neurons predominantly in the frontal and tem-
poral cortex, leading to changes in personality, behavior
and cognitive function. ALS and FTD are now recog-
nized to be at the extremes of a spectrum of the same dis-
order with up to 25% of ALS cases clinically diagnosed
with FTD and approximately 50% of FTD cases display-
ing some degree of motor neuron involvement.1
A GGGGCC hexanucleotide repeat expansion within
the ﬁrst intron of the C9orf72 gene was found to be the
most common genetic defect associated with both ALS
and FTD (referred to as C9ALS/FTD).2,3 The pathogenic
mechanism by which the repeat expansion causes disease
may involve gain-of-toxic-function mechanisms, namely
RNA toxicity2,4-8 and protein toxicity by aberrant dipep-
tide repeat protein (DPR) accumulation.9-13 Alterna-
tively, reduced C9orf72 mRNA levels in a range of
patient tissues and patient-derived cell lines2,14-18 and
reduced C9orf72 protein levels in the frontal cortex of
C9ALS/FTD patients19,20 suggest loss-of-function by
C9orf72 haploinsufﬁciency may also contribute to
C9ALS/FTD. Mild neurodegeneration and cognitive
impairment have been reported in some gain-of-toxic-
function GGGGCC repeat C9orf72 BAC-transgenic
mice21,22 but not others,23,24 while loss-of-function
C9orf72 knockout mice exhibit an immunological rather
than neuronal phenotype.25-29 Thus neither loss- nor
gain-of-function appears sufﬁcient to model all aspects
of disease in vivo, suggesting that all 3 mechanisms might
be conspiring to cause C9ALS/FTD.
The alternatively spliced C9orf72 gene codes for 2 protein
isoforms, a 481 amino acid (aa) “long” isoform (C9orf72L)
and a 222 aa “short” isoform (C9orf72S). C9orf72 does not
show obvious sequence homology to other proteins, but bio-
informatics analysis revealed that the C9orf72 protein is
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structurally related to Differentially Expressed in Normal
and Neoplasia (DENN) domain-containing proteins, which
function as GDP/GTP exchange factors (GEFs) for the Rab
family of GTPases.30,31 Rab GTPases function as molecular
switches that alternate between a GTP-bound active state
and aGDP-bound inactive state. GEFs catalyze the exchange
of GDP for GTP while GTPase activating proteins (GAPs)
catalyze GTP hydrolysis to GDP. GTP-bound, active Rabs
recruit and/or activate a variety of effector molecules and in
doing so Rabs control a range of cellular trafﬁcking events,
including autophagy (reviewed in refs. 32, 33).
Autophagy (derived from the Greek and meaning
“self-eating”) is a highly conserved catabolic process that
involves the delivery of cytosolic components to the lyso-
some for degradation. Macroautophagy, herein referred
to as autophagy, requires the formation of a double
membrane structure called the autophagosome, which
encapsulates cytosolic substrates such as misfolded pro-
teins and damaged organelles, before fusing with the
lysosome to allow bulk degradation and recycling. The
autophagy process can be subdivided into 4 steps, (i)
translocation and initiation, (ii) elongation and cargo
recruitment, (iii) completion, and (iv) lysosome fusion
and degradation (reviewed in ref. 34). A large number of
Rab GTPases have been shown to be involved at each
stage of autophagy (reviewed in ref. 32) (Fig. 1).
Here we summarise the role of C9orf72 in Rab-medi-
ated regulation of autophagy and discuss autophagy dys-
regulation as a pathogenic mechanism in ALS/FTD.
C9orf72 and autophagy induction
While the pathology associatedwithC9ALS/FTD is inmany
ways consistent with other forms of ALS/FTD, including the
classical TDP-43 neuronal cytoplasmic inclusions, C9ALS/
FTD cases are distinguished by the presence of speciﬁc ubiq-
uitin and p62/sequestosome-1 positive, TDP-43 negative,
neuronal cytoplasmic inclusions in the cerebellum, hippo-
campus and neocortex.16,35,36 p62/sequestosome-1 is a well-
characterized autophagy receptor that binds ubiquitinated
substrates and recruits them to the nascent phagosome via
interaction with phagosomal LC3-II (Fig. 1). Because p62/
sequestosome-1 is itself degraded by autophagy in the pro-
cess of delivering substrates, accumulations of p62/sequesto-
some-1 are indicative of defective autophagy.37 Thus, the
presence of p62/sequestosome-1-positive inclusions
together with C9orf72 haploinsufﬁciency suggested the pos-
sibility of defective autophagy by loss of C9orf72 function in
C9ALS/FTD.
To test for a role of C9orf72 in autophagy we depleted
C9orf72 or, conversely, overexpressed C9orf72 in cell
lines and primary neurons and quantiﬁed autophagy by
monitoring LC3-II ﬂux.38 We found that loss of C9orf72
disrupted autophagy at the initiation stage whereas over-
expression of C9orf72 induced autophagy.39 These
results corroborated other reports showing that loss of
C9orf72 led to a disruption in autophagy in neuronal cell
lines40 and in vivo in C9orf72 knockout mice.23,28
The initiation of autophagy is controlled by the
ULK1 autophagy initiation complex, which is com-
prised of Unc-51-like kinase 1 (ULK1), FAK family
kinase-interacting protein of 200 kDa (FIP200), auto-
phagy-related 13 (ATG13) and ATG101.41-44 When
we disrupted the ULK1 complex by depletion of
FIP200, C9orf72 overexpression was no longer able to
induce autophagy indicating that C9orf72 acted at the
level of the ULK1 complex.39 Using immunoprecipita-
tion, in vitro binding and proximity ligation assays we
went on to show a direct interaction between C9orf72
and ULK1, FIP200 and ATG13.39 The interaction
with FIP200 conﬁrmed a previously reported proteo-
mics screen.45 In support of our ﬁndings, C9orf72, in
complex with SMCR8 and WDR41, was indepen-
dently reported to interact with the ULK1 initiation
complex.28
The ULK1 complex is kept inactive by mTOR, which
phosphorylates ULK1 at serine 757.46 Inactivation of
mTOR leads to its release from the ULK1 complex and
ULK1 phosphorylation is lost thereby enhancing ULK1
kinase activity. In turn, ULK1 phosphorylates FIP200
and ATG13 to activate the complex41,46,47 (Fig. 2). The
activated ULK1 complex translocates to the phagophore
to initiate autophagosome formation.42,48 In a series of
experiments aimed at deﬁning the role of C9orf72 in
autophagy initiation we found that depletion of C9orf72
did not affect the ULK1 complex at the level of mTOR,
but rather prevented the translocation of the activated
ULK1 complex to the phagophore.39
C9orf72 as a Rab1a effector
In yeast the translocation of Atg1, the yeast homolog of
ULK1, is regulated by Ypt1, the yeast homolog of Rab149
and in mammalian cells Rab1 has been shown to regulate
the early stages of autophagy.50-52 We therefore investi-
gated whether the C9orf72-mediated regulation of ULK1
complex translocation involved Rab1. In cells depleted of
Rab1a by siRNA treatment or expressing constitutively
GDP-bound, dominant negative Rab1a(S25N), overex-
pression of C9orf72 no longer induced translocation of
the ULK1 initiation complex and autophagy,39 indicating
C9orf72 acted through Rab1a.
The structural homology of C9orf72 with DENN fam-
ily Rab GEF proteins30,31 and the identiﬁcation of
C9orf72 as a potential Rab1a interaction partner in a
yeast 2 hybrid screen39 prompted us to further
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investigate the interaction of C9orf72 and Rab1a in
immunoprecipitation and in-vitro binding assays. Rab1a
interacted with C9orf72 in both assays, but interestingly
C9orf72 preferentially bound to GTP-bound Rab1a.39
Thus our data identiﬁed C9orf72 as an effector of Rab1a
rather than a GEF as would be expected for a DENN
family protein. As a Rab1a effector, C9orf72 was found
to mediate the interaction between Rab1a and the ULK1
initiation complex and proved essential for Rab1a-medi-
ated translocation of the ULK1 complex.39 Thus our data
support a model in which C9orf72 is an effector of
Rab1a that facilitates trafﬁcking of the ULK1 initiation
complex to the phagophore (Fig. 2).
C9orf72 acts in a Rab cascade
While our work shows that C9orf72 is a Rab1a effector,39
others have shown that C9orf72 forms a complex with
SMCR8 and WDR4128,40,53,54 and acts as a GEF for
RAB8a and RAB39b in the autophagy pathway.40 How-
ever, the interaction between the C9orf72/SMCR8/
WDR41 complex and RAB8a or RAB39b appeared to be
mainly through binding with SMCR8, and Rab GEF
activity was only observed when SMCR8 was present.40
As SMCR8 is itself a DENN domain protein,31 it appears
that SMCR8 rather than C9orf72 may mediate the GEF
activity toward Rab8a and Rab39b.
Figure 1. Autophagy and the Rab GTPases. The four stages of autophagy are indicatedwith the different Rabs involved at each stage. 1) Translo-
cation of the ULK1 initiation complex to the phagophore is the ﬁrst step in autophagy initiation. Rab1amediates trafﬁcking of the ULK1 complex
to the phagophore and is involved in delivery of ATG9 positivemembranes to the site of phagophore formation. Rab5 is involved in translocation
of the Class III PI3 kinase complex and delivery of LC3-II. 2) Elongation of the phagophore membrane requires the Class III PI3 kinase complex.
Rab8a, Rab24, Rab32, Rab33b and Rab39b are all involved in autophagosome formation and may aid in elongation by the delivery of additional
membrane via ATG9/ATG2/WIPI1/2. Autophagy substrates are recruited to the growing phagophore by autophagy receptors such as p62/
sequestosome-1 and optineurin. Autophagy receptors bind ubiquitin on the substrates and LC3-II on the nascent phagophore resulting in sub-
strate delivery. 3) After completion and closure, autophagosomes are transported to allow fusion with the lysosome. Rab7 is involved in autopha-
gosome transport while Rab11 delivers multi-vesicular bodies (MVBs) to the autophagosome, which appears to be required for maturation. 4)
Autophagosome fusion with the lysosome allows degradation of the autophagic substrates. Rab7, Rab8b and Rab9 are involved in the fusion of
autophagosomes and lysosomes, a process that may also require Rab24. Finally, autophagic substrates are degraded by the acid hydolases of
the lysosome and recycled back to the cytoplasm.
SMALL GTPASES 3
Sequential activation of Rab GTPases in a cascade-
like fashion allows the correct spatial and temporal
recruitment of successive Rabs in a signal transduc-
tion pathway. In these Rab cascades the upstream
Rab and its effectors recruit the GEF of the next
downstream Rab, while the downstream Rab recruits
the GAP for the upstream Rab (reviewed in ref. 55).
Thus a model emerges in which C9orf72 links auto-
phagy initiation to downstream events via a Rab cas-
cade, involving Rab1a upstream of Rab8a and Rab39b
(Fig. 3). Consistent with this, Rab1 has been shown
to be involved in autophagy initiation39,50,52 whereas
Rab8 and Rab39 are involved in autophagosome mat-
uration56,57 (Fig. 1). Furthermore Rab8a and Rab39b
were shown to interact with the autophagy receptors
optineurin and p62/sequestosome-1 suggesting the
interesting possibility of C9orf72 regulated site-
directed autophagy initiation.40,56
The role of C9orf72 in inﬂammation
Autophagy plays an important role in both innate and
adaptive immunity. Thus, autophagy eliminates invading
pathogens, controls pro-inﬂammatory signaling, regulates
the secretion of immune mediators, and modulates MHC
class II antigen presentation (reviewed in refs. 58, 59, 60).
C9orf72 knockout mice present with varying degrees
of autoimmunity and inﬂammation, accompanied by
splenomegaly and increased expression of inﬂammatory
cytokines.23,25-29 Our study into the regulation of auto-
phagy initiation by C9orf72 indicates that these pheno-
types could be a consequence of compromised
autophagy. In support of this both ULK1 and AMPKa
(an upstream regulator of ULK1) knockout mice show
splenomegaly similar to the C9orf72 knockout mice.61,62
Furthermore, C9orf72 knockout mice show increased
secretion of IL-1ß23 and increased numbers of activated
CD69C T-cells,25 phenotypes that have previously been
reported in autophagy-deﬁcient ATG16L knockout
mice63 and ATG5 knockout mice,64 respectively. Hence
the phenotype of these C9orf72 knockout mice may
relate to a speciﬁc role of C9orf72 in immune-related
autophagy.
In agreement, TANK-binding kinase 1 (TBK1), a
well-known regulator of inﬂammation and autophagy
(reviewed in ref. 65) has been shown to phosphorylate
SMCR8 in the C9orf72/SMCR8/WDR41 complex and
this phosphorylation appears to be important for its
Figure 2. C9orf72 regulates the Rab1a dependent trafﬁcking of the ULK1 complex. Upon inhibition of mTOR, the inhibitory phosphory-
lation of ULK1 is lost, leading to the activation of ULK1. Active ULK1 phosphorylates the other members of the initiation complex, includ-
ing FIP200 and ATG13. Functioning as a Rab1a effector, C9orf72 mediates the interaction between the active ULK1 initiation complex
and GTP-Rab1a within its target membrane. Thus C9orf72 controls the Rab1a dependent trafﬁcking of the ULK1 initiation complex to
the phagophore. How Rab1 is activated in response to autophagy induction is not yet known.
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function in autophagy.40 Furthermore, the C9orf72/
SMCR8/WDR41 complex has been shown to interact
with optineurin, an autophagy substrate receptor
involved in clearance of intracellular bacteria and itself a
TBK1 substrate.40,66 As mutations in both TBK1 and
optineurin have also been associated with ALS/FTD,67,68
a pattern of disrupted immune-related autophagy linked
to the pathogenesis of ALS/FTD is emerging.
Defective autophagy and C9ALS/FTD
C9ALS/FTD patients show speciﬁc p62/sequestosome-1
pathology.16,35,36 To directly test whether this C9ALS/
FTD-associated pathology was linked to C9orf72 hap-
loinsufﬁciency we investigated p62/sequestosome-1 dis-
tribution in cells and neurons depleted of C9orf72. Loss
of C9orf72 resulted in the accumulation of p62/sequesto-
some-1 positive puncta in both HeLa cells and rat corti-
cal neurons and this was speciﬁc to the loss of C9orf72
as reintroduction of C9orf72 in the rat cortical neurons
was sufﬁcient to rescue this accumulation.39 In a similar
experiment, Sellier et al. also demonstrated that reduced
expression of C9orf72 led to the accumulation of p62/
sequestosome-1.40 We next went on to investigate auto-
phagy in C9ALS/FTD patient-derived iNeurons and
found markedly decreased levels of basal autophagy
compared to their age and gender matched controls,
lending further support to C9orf72 haploinsufﬁciency as
a cause of autophagy deﬁcits and p62/sequestosome-1
pathology in C9ALS/FTD.39 If loss of C9orf72 causes
p62/sequestosome-1 pathology in vivo is not yet clear as
p62/sequestosome-1 levels have not yet been reported in
full or neuronal speciﬁc C9orf72 knockout mice.25-29
Interestingly neuronal speciﬁc ablation of C9orf72 did
not lead to the accumulation of ubiquitin-positive inclu-
sions in the spinal cord, hippocampus and frontal cortex,
suggesting that at least in this case loss of neuronal
C9orf72 is not enough to replicate disease associated
ubiquitin pathology.29 It will be of interest to further
characterize the role of C9orf72 in autophagy in the CNS
to establish its relationship with p62/sequestosome-1
and ubiquitin pathology in vivo.
The data from C9orf72 knockout mice show that loss
of C9orf72 does not lead to the overt neurodegeneration
that is typically associated with ALS/FTD.23,25-29 Simi-
larly, GGGGCC repeat C9orf72 BAC-transgenic mice
that model toxic gain-of-function RNA and DPR pathol-
ogy (but retain mouse C9orf72) show no24,69 or mild
neurodegeneration.21,22 Hence it is plausible that
C9orf72 haploinsufﬁciency may be a modiﬁer of
Figure 3. C9orf72 is a central hub in a Rab cascade pathway during autophagy induction. 1) C9orf72 controls the Rab1a-dependent
translocation of the ULK1 initiation complex to the site of phagophore formation by interacting with the ULK1 complex and active GTP-
Rab1a. 2) At the site of phagophore formation, the C9orf72/SMCR8/WDR41 complex functions as a GEF for Rab8a and Rab39b. 3) Active
Rab8a and Rab39b may be involved in delivery of additional membrane to the site of phagophore formation by retrieval of ATG9 posi-
tive membranes. Additional membrane allows elongation of the nascent phagophore and formation of an autophagosome. 4) The auto-
phagy receptors p62/sequestosome-1 and optineurin interact with Rab8a and Rab39b, promoting nucleation and site speciﬁc
recruitment of autophagic substrates to the growing phagophore. Furthermore, Rab8a also recruits TBK1, leading to phosphorylation of
optineurin, SMCR8 and ULK1. The phosphorylation of optineurin enhances its interaction with LC3-II, facilitating substrate delivery and
the progression of autophagy. 5) The Class III PI3 Kinase complex is also required for autophagosome formation. Rab5, activated by
Alsin, delivers the PI3 Kinase complex to the phagophore and also facilitates the recruitment of the ATG7-ATG5 conjugation system
required for LC3-II formation.
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GGGGCC repeat-associated toxic gain-of-function
mechanisms. An attractive possibility is a 2-hit model in
which reduced autophagy by loss of C9orf72 function
exacerbates DPR accumulation and toxicity. Alterna-
tively, defective autophagy caused by C9orf72 haploin-
sufﬁciency in microglia and macrophages may lead to a
failure in the support, and therefore survival, of (motor)
neurons. Indeed, we know from studies of mutant
SOD1-related ALS that ALS is a non-cell-autonomous
process that critically involves glial cells.70,71 Further-
more, the association of C9orf72 with immune-related
autophagy discussed above may provide a direct link to
the neuroinﬂammation that is observed in ALS/FTD.
Future experiments should dissect any direct pathogenic
effects of immune-related autophagy in ALS/FTD by, for
example, genetic inhibition of autophagy in speciﬁc cell
lineages such as myeloid cells.
Conclusions
Autophagy deﬁcits appear to have a central role in
ALS/FTD. Indeed, in addition to C9orf72, TBK1 and
optineurin many other genes implicated in the auto-
phagy/lysosomal pathway have been associated with
ALS/FTD, including Alsin (a Rab5 GEF), charged
multivesicular body protein-2B (CHMP2B), p62/
sequestosome-1, progranulin, ubiquilin-2, valosin-con-
taining protein (VCP), Fig4, and TMEM106b (Fig. 4).
Future research will have to elucidate the contribution
of autophagy to the disease process and determine the
effect of disease-associated mutations in neuronal and
non-neuronal cells. Furthermore, as emerging evi-
dence implicates multiple Rab GTPases in ALS/FTD
and other neurodegenerative diseases, such as Parkin-
son disease, studying the speciﬁc functions of Rab
GTPases in the CNS is warranted.
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